Brazil is currently the largest Latin American market in terms of patient numbers and sales of legal cannabis products – despite the country’s restricted access. What’s promising is the potential for upcoming reform in which domestic cultivation would be regulated for the first time and cannabis products could be registered without finished clinical trials.
You’ll get insights on:
- What opportunities the current program offers to companies interested in exporting to Brazil.
- The expected timeline for program reform, which could create significant new business opportunities.
- How to start getting ready, in advance of reform, to cultivate marijuana in Brazil and register cannabis products that haven’t completed clinical trials.